Covid-19 drugs, Covid-19, Covid drugs, Coronavirus drugs

From the Mayo Clinic, 2-2022:

Some of the treatments authorized by the FDA:

"The FDA has authorized for emergency use a drug called Paxlovid... Paxlovid is authorized to treat mild to moderate COVID-19 in people age 12 and older who are at higher risk of serious illness. "
...
"The FDA has authorized for emergency use another drug called molnupiravir to treat mild to moderate COVID-19 in adults who are at higher risk of serious illness and not able to take other treatments."

Immune-based therapy... "Researchers study immune-based therapies, including convalescent plasma, mesenchymal stem cells and monoclonal antibodies. Monoclonal antibodies are proteins created in a lab that can help the immune system fight off viruses."

Some monoclonal antibodies cannot treat COVID-19 caused by the omicron variant and some can.

"To be most effective, these medications need to be given soon after COVID-19 symptoms start and before hospitalization."
...
Convalescent plasma is blood donated by people who've recovered from COVID-19. Convalescent plasma with high antibodies may be used to treat some hospitalized people with COVID-19 who are either early in their illness or have weakened immune systems.

...
Monoclonal antibody... "The FDA has authorized for emergency use the monoclonal antibody combination of tixagevimab and cilgavimab (Evusheld) to prevent COVID-19 in some people with weakened immune systems or a history of severe reactions to a COVID-19 vaccine."